Valproic acid (VPA) reduced ACE2 expression in different epithelial and endothelial cell lines (Saiz et al., 2021), and TMPRSS2 expression in prostate cancer cells (Fortson et al., 2011). Here, ACE2 is linked to prostate cancer.